Dieye, T. N., Ndiaye, B. P., Dieng, A. B., Fall, M., Brittain, N., Vermaak, S., . . . McShane, H. Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationDieye, Tandakha N., et al. Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects. Public Library of Science (PLoS).
MLA (9th ed.) CitationDieye, Tandakha N., et al. Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.